RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Lebanon, NH · +128 more sites
Breast Cancer clinical trials in Lebanon, NH
10 recruiting breast cancer studies with a site in Lebanon, NH.
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Concord, NH · Lebanon, NH · Manchester, NH · +1223 more sites
RecruitingPhase 3NCT06072612
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Sponsor: BriaCell Therapeutics Corporation
Lebanon, NH · +78 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Concord, NH · Lebanon, NH · Londonderry, NH · +825 more sites
RecruitingNot applicableNCT06258993
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
Sponsor: Dartmouth-Hitchcock Medical Center
Lebanon, NH
RecruitingNot applicableNCT06400563
MRg-NIRS Imaging System Breast Cancer Trial
Sponsor: Keith D. Paulsen
Lebanon, NH
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Concord, NH · Lebanon, NH · Manchester, NH · +809 more sites
RecruitingPhase 1NCT02926690
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Sponsor: OncoTherapy Science, Inc.
Lebanon, NH · +7 more sites
RecruitingPhase 2NCT05933395
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Sponsor: Dartmouth-Hitchcock Medical Center
Lebanon, NH
Not yet recruitingPhase 1 / Phase 2NCT07612254
aPBI Re-irradiation
Sponsor: Dartmouth-Hitchcock Medical Center
Lebanon, NH
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.